MGAM and type 2 diabetes mellitus: The presence of highly specific anti-MG-Fib autoantibodies or anti-Fib-AGEs autoantibodies in the sera of T2DM (54%), ATH (33%), and T2DM-ATH (65%) patients is in agreement with our in vitro study.